Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (6): 1070-1072    DOI: 10.12892/ejgo4969.2019
Case Report Previous articles | Next articles
Uterine smooth muscle tumor of uncertain malignant potential
A.C. da Silva1, T. Calapodopulos1, T.C. Guaresqui1, J.C. Saldanha2, E.F.C. Murta1, R.S. Nomelini1, *()
1Research Institute of Oncology (IPON)/Department of Gynecology and Obstetrics, Federal University of Triângulo Mineiro, Uberaba -MG, Brazil
2Service of Surgical Pathology, Federal University of Triângulo Mineiro, Uberaba -MG, Brazil
Download:  PDF(415KB)  ( 174 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Uterine smooth muscle tumor of uncertain malignant potential (STUMP) are uterine neoplasms with mesenchymal characteristics between benign leiomyomas and malignant leiomyosarcomas. A 41-year-old patient sought the Gynecology and Obstetrics Service of the Federal University of the Triangulo Mineiro for parous myoma and severe anemia.The patient underwent abdominal hysterectomy and the anatomicopathologic results showed mild nuclear atypia, hypercellularity, and foci of necrosis, which confirmed the diagnosis of STUMP. The patient was followed up for 45 months without recurrence of the disease.

Key words:  Smooth muscle tumor      Uterine neoplasms      Leiomyoma      STUMP      Uterine cancer     
Published:  10 December 2019     
*Corresponding Author(s):  R.S. NOMELINI     E-mail:  rosekeila@terra.com.br

Cite this article: 

A.C. da Silva, T. Calapodopulos, T.C. Guaresqui, J.C. Saldanha, E.F.C. Murta, R.S. Nomelini. Uterine smooth muscle tumor of uncertain malignant potential. European Journal of Gynaecological Oncology, 2019, 40(6): 1070-1072.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4969.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I6/1070

[1] Michelle F. Benoit, Kristy K. Ward. Uterine Cancer Normogram to Predict Lymph Node Metastasis: Comparison to the Mayo Algorithm and an External Validation of a Model in a North American Population[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 681-684.
[2] Chiharu Mizoguchi, Harunobu Matsumoto, Kaei Nasu, Kentaro Kai, Motoki Arakane, Hisashi Narahara. Collision tumour of endometrial stromal sarcoma, uterine tumour resembling ovarian sex-cord tumour, and leiomyoma[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 634-637.
[3] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[4] J. H. Sang, J. I. Choi, S.-H. Chung. Case series of uterine smooth muscle tumors of uncertain malignant potential (STUMP)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 492-494.
[5] K. Sonoda, M. Nogami, K. Kodama, Y. Oda, K. Kato. Re-evaluation of preoperative endometrial smears for the cytodiagnosis of uterine leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 167-170.
[6] S. Srdelić Mihalj, V. Čapkun, I. Kuzmić-Prusac. High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 16-22.
[7] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[8] N. Okabe, M. Fujiwara, M. Mochizuki, K. Ohtsuka, Y. Nishigaya, Y. Kobayashi, H. Kamma. CD34-positive uterine lipoleiomyoma in a postmenopausal woman with chronic glomerulonephritis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1060-1063.
[9] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879-882.
[10] M. Biedka, R. Makarewicz. Is there a place for brachytherapy for patients with ovarian cancer?[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 373-379.
[11] S. Piątek, A. Fleming, M. Gajewska, M. Wielgoś. Uterine angioleiomyoma with extra-gonadal arterial supply from the splenic artery - case report and literature review[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 471-473.
[12] L.M. Langermans, A. Salajan, C. Riera. Retroperitoneal benign leiomyoma is a challenging diagnosis in gynecology: report of two cases[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 318-320.
[13] M. F. Benoit. Surgical staging and differential protein expression in endometrial cancers[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 859-866.
[14] M.O. Matsuya, K. Sugihara, C. Yaguchi, H. Itoh, H. Kitamura, N. Kanayama, K. Arahori. Leiomyomatosis peritonealis disseminata with aromatase cytochrome P450 expression in a postmenopausal woman: a case study with literature review[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 838-842.
[15] Arum Lee, Tae-Hee Kim, Hae-Hyeog Lee, Jun-Mo Kim, Yeon-Suk Kim. Expression of Jun activation domain-binding protein 1 and p27 Kip1 in endometrial polyps and uterine leiomyomas[J]. European Journal of Gynaecological Oncology, 2018, 39(4): 533-537.
No Suggested Reading articles found!